Miller Aine 4
4 · Theravance Biopharma, Inc. · Filed May 21, 2025
Insider Transaction Report
Form 4
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
- Tax Payment
Ordinary Shares
2025-05-20$9.45/sh−9,701$91,674→ 214,990 total - Award
Ordinary Shares
2025-05-19+10,430→ 224,691 total
Footnotes (2)
- [F1]On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On May 19, 2025, the performance conditions were deemed achieved as to 10,430 RSUs, and such RSUs are eligible to vest based on the reporting person's continued service.
- [F2]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.